<DOC>
	<DOCNO>NCT01448447</DOCNO>
	<brief_summary>This study evaluate local control rate , cosmetic result , complication rate breast brachytherapy deliver use MammoSite-ML速 used sole method radiation therapy boost technique patient stage I-II carcinoma breast ( &lt; 3 cm ) , ( non-lobular histology ) treat lumpectomy histologically negative surgical margin least 2 mm , negative axillary lymph node , DCIS . Hypotheses : - For select patient stage I breast carcinoma Ductal Carcinoma In Situ ( DCIS ) , radiation therapy deliver brachytherapy alone use MammoSite-ML速 technically feasible reproducible acceptable complication rate . - Cosmetic result brachytherapy similar obtain traditional whole breast external beam radiation therapy . - Local tumor control rate breast brachytherapy similar conventional external beam radiation therapy , less inconvenience potentially less cost patient , give selection criterion minimize risk clinically significant multicentric extensive residual carcinoma follow lumpectomy .</brief_summary>
	<brief_title>Phase IV Trial Evaluate Breast Brachytherapy Using Mammosite-Ml速</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma Situ</mesh_term>
	<mesh_term>Carcinoma , Ductal</mesh_term>
	<mesh_term>Carcinoma , Intraductal , Noninfiltrating</mesh_term>
	<criteria>Women , age least 45 year Zubrod performance status 02 AJCC Stage III ( T1T2 , N0 M0 ) breast cancer Maximum tumor dimension &lt; 3 cm Invasive ductal , medullary , papillary , tubular , colloid ( mucinous ) histologies Unifocal breast cancer Unilateral breast cancer ( synchronous previous contralateral breast cancer ) Lumpectomy negative surgical margin least 2 mm reexcision specimen negative surgical margin least 2 mm Ductal Carcinoma InSitu Negative axillary lymph node invasive breast cancer ( sentinel node biopsy standard level III dissection &gt; 6 node remove ) Time interval final breast surgery brachytherapy load less 8 week At least 2 mm breast tissue skin MammoSite速 balloon surface ( prefer &gt; 5 mm ) If chemotherapy plan , must begin earlier 2 week follow completion radiation therapy . If chemotherapy first , minimum 2 week last cycle must elapse prior start radiation therapy . Signed studyspecific consent form Invasive lobular histology Nonepithelial breast malignancy sarcoma lymphoma Multifocal multicentric invasive carcinoma Extensive intraductal component ( EIC ) Paget 's disease nipple Skin involvement tumor , regardless tumor size Positive axillary lymph node Distant metastases Collagen vascular disease ( scleroderma ) Pregnant lactate woman , due potential exposure fetus RT unknown effect RT lactate female ( negative pregnancy test woman childbearing age ) Any previously treat synchronous contralateral breast carcinoma Patients psychiatric addictive disorder would preclude obtain informed Consent Men</criteria>
	<gender>Female</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
</DOC>